Want to join the conversation?
Oil and gas producer $OKE reported 4Q15 net income attributable to company of $25.5MM or $0.12 per diluted share, down 73% versus $94.5MM or $0.45 per diluted share in 4Q14, hurt by lower revenue and an impairment of equity investments. Total revenue fell 32.1% to $1.9Bil versus $2.9Bil YoverY.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.